Kevin Cheng is a Partner at MVM Partners, specializing in investments in growth-stage healthcare companies. They currently serve as a Board Member at BioProtect Ltd and OSSIO, and previously held board observer roles at Cheetah Medical and Paragon 28. Kevin earned a PhD in Oncology from the University of Cambridge and served as a College Supervisor there, teaching biochemistry and molecular biology. They conducted research as a PhD Researcher at the Medical Research Council, focusing on neural development pathways.
This person is not in the org chart
This person is not in any teams
This person is not in any offices